Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 2;22(1):236.
doi: 10.1186/s12933-023-01974-6.

Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study

Affiliations

Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study

Zirui Liu et al. Cardiovasc Diabetol. .

Abstract

Background: The presence of type 1 diabetes mellitus (T1DM) has been demonstrated to pose an increased risk for developing cardiovascular diseases (CVDs). However, the causal relationships between T1DM and CVDs remain unclear due to the uncontrolled confounding factors and reverse causation bias of the observational studies.

Methods: Summary statistics of T1DM and seven CVDs from the largest available genome-wide association studies (GWAS) of European ancestry and FinnGen biobank were extracted for the primary MR analysis, and the analysis was replicated using UK biobank (UKBB) for validation. Three complementary methods: inverse variance weighted (IVW), weighted median, and MR-Egger were used for the MR estimates. The potential pleiotropic effects were assessed by MR-Egger intercept and MR-PRESSO global test. Additionally, multivariable MR (MVMR) analysis was performed to examine whether T1DM has independent effects on CVDs with adjustment of potential confounding factors. Moreover, a two-step MR approach was used to assess the potential mediating effects of these factors on the causal effects between T1DM and CVDs.

Results: Causal effects of T1DM on peripheral atherosclerosis (odds ratio [OR] = 1.06, 95% confidence interval [CI]: 1.02-1.10; p = 0.002)] and coronary atherosclerosis (OR = 1.03, 95% CI: 1.01-1.05; p = 0.001) were found. The results were less likely to be biased by the horizontal pleiotropic effects (both p values of MR-Egger intercept and MR-PRESSO Global test > 0.05). In the following MVMR analysis, we found the causal effects of T1DM on peripheral atherosclerosis and coronary atherosclerosis remain significant after adjusting for a series of potential confounding factors. Moreover, we found that hypertension partly mediated the causal effects of T1DM on peripheral atherosclerosis (proportion of mediation effect in total effect: 11.47%, 95% CI: 3.23-19.71%) and coronary atherosclerosis (16.84%, 95% CI: 5.35-28.33%). We didn't find significant causal relationships between T1DM and other CVDs, including heart failure (HF), coronary artery disease (CAD), atrial fibrillation (AF), myocardial infarction (MI) and stroke. For the reverse MR from CVD to T1DM, no significant causal relationships were identified.

Conclusion: This MR study provided evidence supporting the causal effect of T1DM on peripheral atherosclerosis and coronary atherosclerosis, with hypertension partly mediating this effect.

Keywords: Cardiovascular disease; Mendelian randomization; Type 1 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Study overview. Notes: Data in the primary analysis were extracted from T1DM [18], MI [20], HF [21], AF [23], CAD [22], stroke [24], PAS and CAS [25] respectively. GWAS, genome-wide association studies; T1DM, type 1 diabetes mellitus; MI, myocardial infraction; HF, heart failure; AF; atrial fibrillation; CAD, coronary artery disease; PAS, peripheral atherosclerosis; CAS, coronary atherosclerosis; SNPs, single nucleotide polymorphisms; MR, mendelian randomization; IVW, Inverse variance weighted
Fig. 2
Fig. 2
Causal relationship between T1DM and peripheral/coronary atherosclerosis. Notes: Fig. 2a-b showed the scatter plots and causal estimates from three different methods. Figure 2c-d showed the leave-one-out plots of the sensitivity analysis
Fig. 3
Fig. 3
MR results between T1DM and the seven CVDs

Similar articles

Cited by

References

    1. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449–62. doi: 10.1016/S0140-6736(18)31320-5. - DOI - PMC - PubMed
    1. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Ã. Type 1 diabetes mellitus. Nat Reviews Disease Primers. 2017;3:17016. doi: 10.1038/nrdp.2017.16. - DOI - PubMed
    1. Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, Beran D. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64(12):2741–50. doi: 10.1007/s00125-021-05571-8. - DOI - PMC - PubMed
    1. Lawrence JM, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C, Marcovina SM, Mayer-Davis EJ, Hamman RF, Dolan L, et al. Trends in Prevalence of Type 1 and type 2 diabetes in children and adolescents in the US, 2001–2017. JAMA. 2021;326(8):717–27. doi: 10.1001/jama.2021.11165. - DOI - PMC - PubMed
    1. Vallianou NG, Stratigou T, Geladari E, Tessier CM, Mantzoros CS, Dalamaga M. Diabetes type 1: can it be treated as an autoimmune disorder? Rev Endocr Metab Disord. 2021;22(4):859–76. doi: 10.1007/s11154-021-09642-4. - DOI - PubMed

Publication types

MeSH terms